Reviva Pharmaceuticals
RVPH
RVPH
33 hedge funds and large institutions have $14.9M invested in Reviva Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
9
Reduced
7
Closed
5
Calls
$422K
Puts
$132K
Net Calls
+$290K
Net Calls Change
-$26K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$4.59M |
| 2 |
Millennium Management
New York
|
+$852K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$723K |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$86.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$66.5K |
Top Sellers
| 1 |
ECM
EMC Capital Management
Houston,
Texas
|
-$3.66M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$1.31M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$303K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$187K |
| 5 |
Morgan Stanley
New York
|
-$17K |
